Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A traditional Chinese medicine oral liquid for treating leukopenia after chemotherapy

A technology for leukopenia and traditional Chinese medicine oral liquid, applied in the field of medicine, can solve problems such as unstable curative effect, unsafe cost, etc., and achieve the effects of affirming curative effect, improving bone marrow suppression, and increasing white blood cells

Inactive Publication Date: 2016-11-30
HENAN UNIV OF CHINESE MEDICINE
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] In view of the above situation, in order to overcome the defects of the prior art, the object of the present invention is to provide a Chinese medicine oral liquid for the treatment of post-chemotherapy leukopenia, which can effectively solve the problem of medication for the treatment of post-chemotherapy leukopenia, prevent infection from being induced, and have unstable curative effect. , the problem of insecurity and high cost

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A traditional Chinese medicine oral liquid for treating leukopenia after chemotherapy
  • A traditional Chinese medicine oral liquid for treating leukopenia after chemotherapy

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0010] In specific implementation, the oral liquid of the present invention can also be made from the following raw materials in parts by weight: 10 parts of Atractylodes macrocephala, 12 parts of Bai Fuling, 10 parts of Rhizoma Polygonatum, 10 parts of mulberry fruit, 10 parts of Eclipta chinensis, 10 parts of Ligustrum lucidum , 6 parts of Sclera sinensis, 10 parts of cypress cypress, 6 parts of sargassum and 10 parts of syringa, wherein, the above-mentioned raw medicines are mixed together, each time adding water of 4 times the weight of the raw medicines or a volume concentration of 70% decocting 2 times, 70 minutes each time, soaking in water or ethanol for 1 hour when decocting for the first time, combining the 2 decoctions, and filtering to obtain.

Embodiment 2

[0012] In specific implementation, the oral liquid of the present invention can also be made from the following raw materials in parts by weight: 20 parts of Atractylodes macrocephala, 18 parts of Bai Fuling, 30 parts of Polygonatum, 20 parts of mulberry fruit, 15 parts of Eclipta chinensis, and 15 parts of Ligustrum lucidum , 10 parts of S. chinensis, 18 parts of cypresses, 10 parts of sargassum and 20 parts of syringae, wherein, the above-mentioned raw medicines are mixed together, and the water of 5 times the weight of the raw medicines is added each time or the volume concentration is 70% decocting 2 times, 70 minutes each time, soaking in water or ethanol for 1 hour when decocting for the first time, combining the 2 decoctions, and filtering to obtain.

Embodiment 3

[0014] During specific implementation, the oral liquid of the present invention can also be made from the following raw materials in parts by weight: 30 parts of Atractylodes macrocephala, 25 parts of Bai Fuling, 50 parts of Rhizoma Polygonatum, 30 parts of mulberry fruit, 20 parts of Eclipta chinensis, 20 parts of Ligustrum lucidum , 15 parts of Sclera sinensis, 25 parts of cypress cypress, 15 parts of sargassum and 30 parts of syringa, wherein, the above-mentioned raw materials are mixed together, and the water of 6 times the weight of the raw materials is added each time or the volume concentration is 70% decocting 2 times, 70 minutes each time, soaking in water or ethanol for 1 hour when decocting for the first time, combining the 2 decoctions, and filtering to obtain.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a traditional Chinese medicine oral liquid for treating leukopenia after chemotherapy, which effectively solves the problems of medication in the treatment of leukopenia after chemotherapy, prevention of induced infection, unstable curative effect, unsafety and high cost, and consists of the following raw materials in parts by weight Drug preparation: 10‑30 parts of Atractylodes macrocephala, 12‑25 parts of Baitucka cocos, 10‑50 parts of sealwort, 10‑30 parts of mulberry, 10‑20 parts of Eclipta chinensis, 10‑20 parts of Ligustrum lucidum, 6‑5 parts of black bone vine 15 parts, 10‑25 parts of cypress, 6‑15 parts of syringa and 10‑30 parts of Sage, mix the above raw materials, add water or ethanol, decoct twice, combine the decoction twice, filter, that is Therefore, the present invention has the functions of invigorating the spleen and tonifying the kidney, detoxifying and removing blood stasis, and increasing white blood cells. It has a definite curative effect in improving the myelosuppression of the chemotherapy body, and is an innovation in the medicine for assisting tumor chemotherapy.

Description

technical field [0001] The invention relates to the field of medicine, in particular to a traditional Chinese medicine oral liquid for treating leukopenia after chemotherapy. Background technique [0002] Tumor is one of the most serious diseases threatening human beings in contemporary times. Surgery, radiotherapy and chemotherapy are the three main means of clinical treatment of tumors, among which chemotherapy kills the residual tumor cells in the patient's body, which can improve the curative effect and prognosis. However, anticancer drugs lack specific selectivity. While killing cancer cells, they can also kill normal cells, especially for the vigorously proliferating bone marrow hematopoietic cells. Leukopenia is a common complication after chemotherapy in patients with malignant tumors. disease. Its side effects often delay or interrupt chemotherapy. [0003] At present, Western medicine generally includes low-dose hormone therapy for the prevention and treatment o...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K36/8969A61P7/00A61P35/00
Inventor 李晓冰刘现辉董文杰程凯展俊平谢忠礼郭洪涛崔璨王君明李瑞琴郭晓娜
Owner HENAN UNIV OF CHINESE MEDICINE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com